Article Details
Retrieved on: 2023-12-26 21:07:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SEATTLE & EXTON, Pa., December 26, 2023--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here